Clinical Trials on Tyrosinemia Type 1 in Austria

Total 3582 results

Novo Nordisk A/S

Completed

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Medical University of Vienna
National Bank of Austria

Unknown

Interventions to Prevent Adolescents With Type 1 Diabetes From Long-term Complications

Diabetes Mellitus, Type 1

Austria
Arecor Limited

Completed

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Diabetes Mellitus, Type 1

Austria
University of Cambridge
Juvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaborators

Unknown

An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA) (INNODIA)

Type 1 Diabetes Mellitus

Austria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
Novo Nordisk A/S

Completed

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works

Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
University of California, San Francisco
Juvenile Diabetes Research Foundation

Completed

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDM

United States, Australia
REMD Biotherapeutics, Inc.

Completed

Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus

United States
John Hunter Children's Hospital
Sydney Children's Hospitals Network; Royal Children's Hospital; Royal North Shore... and other collaborators

Unknown

Bolus Insulin Card Calculator Randomised Controlled Study

Type 1 Diabetes

Australia
Metronom Health
Medical University of Graz

Unknown

Metronom Continuous Glucose Monitoring System

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabete Mellitus

Austria, Denmark
Krankenhaus Barmherzige Schwestern Linz
Medical University of Vienna

Completed

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2) (TRICIN)

Cervical Intraepithelial Neoplasia Grade 1 | Cervical Intraepithelial Neoplasia Grade 2

Austria
Novo Nordisk A/S

Completed

The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)

Completed

Tocilizumab (TCZ) in New-onset Type 1 Diabetes (EXTEND)

Type 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes Mellitus

United States, Australia
Eli Lilly and Company

Completed

A Study of LY3209590 in Participants With Type 1 Diabetes

Type 1 Diabetes Mellitus

United States, Spain, Germany, Puerto Rico, Austria
Boehringer Ingelheim
Eli Lilly and Company

Completed

Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days

Diabetes Mellitus, Type 1

Austria, Germany
GeNeuro Australia PTY Ltd
Southern Star Research Pty Ltd.

Completed

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years (RAINBOW-T1D)

Diabetes Mellitus Type 1

Australia
The University of New South Wales
National Health and Medical Research Council, Australia; Novo Nordisk A/S; Sydney...

Completed

Rosiglitazone and Insulin in T1DM Adolescents

Type 1 Diabetes | Puberty: >Tanner 2 Breast Development or Testis >4ml

Australia
Medtronic Diabetes

Completed

Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics

Type 1 Diabetes Mellitus | Type2 Diabetes Mellitus

United States
ViaCyte

Terminated

A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus (VC01-103)

Type 1 Diabetes

United States
Landeskrankenhaus Feldkirch

Completed

Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study

Diabetic Peripheral Neuropathy | Diabetes Mellitus Type I | Nerve Conduction Study Not Performed

Austria
Mozart Therapeutics Australia Pty Ltd

Not yet recruiting

Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients

Type 1 Diabetes | Celiac Disease | Healthy Volunteers

Australia
Novo Nordisk A/S

Completed

Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
National Institute of Diabetes and Digestive and...
Juvenile Diabetes Research Foundation

Terminated

Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)

Type1 Diabetes Mellitus

United States, Australia, Italy, United Kingdom, Sweden, Canada
National Institute of Diabetes and Digestive and...
National Institutes of Health (NIH)

Recruiting

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes (TN25)

Type 1 Diabetes Mellitus

United States, Australia
Mannkind Corporation

Completed

Afrezza With Basal Combination (ABC)

Type 1 Diabetes

United States
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Rituximab in New Onset Type 1 Diabetes (TN05)

Type 1 Diabetes Mellitus

United States, Canada, Italy, Australia
Medical University of Vienna

Completed

Correlation of Flicker Induced and Flow Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers.

Hypertension | Diabetes Mellitus, Type 1 | Hypercholesterolemia | Regional Blood Flow

Austria
AstraZeneca

Completed

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Australia
Zucara Therapeutics Inc.

Recruiting

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes (ZONE)

Type 1 Diabetes Mellitus With Hypoglycemia

United States, Canada
Sanofi

Completed

6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes (PRESCHOOL)

Type 1 Diabetes Mellitus

United States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
John Hunter Hospital

Completed

Detection of Vascular Injury in Diabetes Through Eye and Nailfold Data (DIVIDEND) - A Pilot Study (DIVIDEND)

Type 1 Diabetes Mellitus

Australia
University of Surrey
UK Civil Aviation Authority; Irish Civil Aviation Authority; Austrian Civil Aviation...

Suspended

Use of Dexcom G6 in Commercial Pilots With Insulin Treated Diabetes (DEXFLY)

Type 1 Diabetes

Austria, Ireland, United Kingdom
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes (PRONTO-T1D)

Type 1 Diabetes Mellitus

Italy, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
Gilead Sciences

Completed

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial (ROCKET II)

HIV-1

Austria, Germany, Italy, Spain
Andromeda Biotech Ltd.

Completed

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults (DIA-AID2)

Type 1 Diabetes Mellitus

United States, Russian Federation, Israel, Spain, Lithuania, Germany, Austria, Belarus, Canada, Czech Republic, Finland, Hungary, Italy, Poland
Biodel

Completed

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Type 1 Diabetes Mellitus

United States
Pfizer

Terminated

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Advanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)

United States, Spain, Hong Kong, Belgium, Australia, France
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 640G Insulin Pump

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Australia
Medical University of Vienna

Terminated

Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-dependent Diabetes Mellitus (IDDM)

Diabetes Mellitus, Type 1 | Diabetic Retinopathy

Austria
Medical University of Vienna

Completed

The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp

Diabetes Mellitus, Type 1 | Insulin | Retina | Regional Blood Flow

Austria
Eli Lilly and Company

Completed

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes (PRONTO-Peds)

Type 1 Diabetes Mellitus

United States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
Texas Diabetes & Endocrinology, P.A.
Amylin Pharmaceuticals, LLC.

Terminated

Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port

Type 1 Diabetes | Type 2 Diabetes

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1)

Type 1 Diabetes Mellitus

United States, Austria, Germany, Italy, Spain, United Kingdom, Belgium, Mexico, Israel, Hungary, Canada, Australia, Denmark, Sweden, Romania, France, Finland

Clinical Trials on Tyrosinemia Type 1 in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations